Displaying 21 to 40 of 49 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Dynavax Technologies Corp |
United States | N/A |
||
|
|
Eiger BioPharmaceuticals A biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. |
United States | 1 Feb 2009 | Series A |
|
|
|
Essentialis Inc Developing a novel therapy for the treatment of dyslipidemia. |
United States | 1 Oct 2010 | Series B |
|
|
|
Hamilton Pharmaceuticals Inc Developing novel treatments for central nervous system disease. |
United States | N/A |
||
|
|
InteKrin Therapeutics Inc Biopharmaceutical company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.. |
United States | 1 Aug 2008 | Series C Active |
|
|
|
InterMune Inc Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
United States | N/A |
||
|
|
Keryx Biopharmaceuticals Inc |
United States | N/A Active |
||
|
|
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
United States | N/A Active |
||
|
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products |
United States | 1 Jan 2010 | Series D Active |
|
|
|
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. |
United States | N/A Active |
||
|
|
Nora Therapeutics Inc Specialty biopharmaceutical company that focuses on developing therapeutics to address clinical unmet needs in reproductive medicine. |
United States | N/A |
||
|
|
OncoGenex Pharmaceuticals A biopharmaceutical company committed to the development and commercialization of new cancer therapies. |
United States | N/A |
||
|
|
Palatin Technologies Inc Develops peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems |
United States | N/A |
||
|
|
Pepgen Corp Biopharmaceutical company engaged in the development of novel autoimmune, inflammatory, and viral therapies. |
United States | N/A |
||
|
|
Prestwick Pharmaceuticals Inc A specialty pharmaceutical company engaged in the development and marketing of drugs for diseases of the CNS. |
United States | N/A |
||
|
|
Rempex Pharmaceuticals Inc Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company. |
United States | 1 Nov 2011 | Series B Initial investment. Round participant. Active |
|
|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jun 2011 | Venture |
|
|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jan 2010 | Series D |
|
|
|
Sagent Pharmaceuticals Is an international specialty injectable pharmaceutical company bringing finished pharmaceutical products to the U.S. market. |
United States | N/A |
||
|
|
SentreHEART Inc A medical device company that has developed catheter-based solutions to address unmet clinical needs. |
United States | 1 Jun 2012 | Series C Initial investment. Round participant. Active |